Patents by Inventor Danny Leung

Danny Leung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Classification of objects
    Patent number: 10638301
    Abstract: Each known operating system, software, or hardware can correspond to a list of identifiable attributes that is used to uniquely identify the operating system, software, or hardware of interest. By using these identifiable attributes in rules, fingerprints can be generated that define the existence of an object (e.g. operating systems, software and hardware). By using the generated fingerprints via a discovery tool, the existence of the objects can be determined within an environment (e.g. computing device, computing network).
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: April 28, 2020
    Assignee: BDNA Corporation
    Inventors: Alexander Meau, Danny Leung
  • CLASSIFICATION OF OBJECTS
    Publication number: 20180295494
    Abstract: Each known operating system, software, or hardware can correspond to a list of identifiable attributes that is used to uniquely identify the operating system, software, or hardware of interest. By using these identifiable attributes in rules, fingerprints can be generated that define the existence of an object (e.g. operating systems, software and hardware). By using the generated fingerprints via a discovery tool, the existence of the objects can be determined within an environment (e.g. computing device, computing network).
    Type: Application
    Filed: September 15, 2017
    Publication date: October 11, 2018
    Inventors: Alexander Meau, Danny Leung
  • METHODS OF TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20100204317
    Abstract: This invention is directed to the use of TOFA in the treatment of acne and other dermatological disorders. This invention is also directed to pharmaceutical compositions comprising TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 12, 2010
    Applicant: QLT INC.
    Inventors: David W.C. Hunt, Jerome Arthur Morris, Huijun Jiang, Danny Leung, Ronald Erwin Boch
  • Antiproliferative 1,2,3-thiadiazole compounds
    Patent number: 6420400
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 16, 2002
    Assignee: Kinetek Pharmaceuticals, Inc.
    Inventors: Zaihui Zhang, Jun Yan, Danny Leung, Shisen Wang, Penelope C. Costello, Jasbinder Sanghera
  • Pyrazole compounds
    Publication number: 20020042501
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
    Type: Application
    Filed: December 22, 2000
    Publication date: April 11, 2002
    Inventors: Zaihui Zhang, Jun Yan, Danny Leung, Penelope C. Costello, Jasbinder Sanghera, Timothy Scott Daynard, Shisen Wang, Mikhail Chafeev
  • Pyrazole compounds
    Patent number: 6214813
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: April 10, 2001
    Assignee: Kinetek Pharmaceuticals, Inc.
    Inventors: Zaihui Zhang, Jun Yan, Danny Leung, Penelope C. Costello, Jasbinder Sanghera